We were delighted to attend the 9th German Pharm-Tox Summit, on March 13–15, 2024, in Munich, Germany.
The GPTS is organized by the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) together with the Austrian Society of Toxicology (ASTOX), Austrian Pharmacological Society (APHAR) and the Association for Applied Human Pharmacology (AGAH). The program, with three plenary talks, various symposia including one by the Paul-Martini-Foundation, many short talks and poster sessions, provided exciting insights into cutting-edge topics of experimental and clinical pharmacology and toxicology, and fostered scientific interactions and collaborations across the borders of our disciplines. Principal Scientist, Susanne Stalford was invited to speak on ‘Developing an in silico framework to enable next generation carcinogenicity assessment for pharmaceuticals’